Opendata, web and dolomites

ENDOGI SIGNED

The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ENDOGI project word cloud

Explore the words cloud of the ENDOGI project. It provides you a very rough idea of what is the project "ENDOGI" about.

device    complications    insertion    guidewire    carry    validate    post    savings    20    pancreatic    extended    hepatic    placement    settings    consequence    multiple    pancreatography    times    urinary    endoscope    day    narrowing    ducts    feasibility    duct    disrupt    retrograde    pancreatitis    disease    patency    procedure    endogi    launch    tested    preliminary    ischemia    80    drainage    diseases    plastic    ercp    hospitalizations    initially    regulatory    medical    penetrate    lumen    biliary    clinical    prevent    50    prototype    jaundice    disorders    stent    market    urgent    hospitalization    first    specially    urologic    cannulations    certifications    securing    innovation    models    completely    secure    patented    reduce    330    stenting    human    stenosis    stents    passage    mps    obtain    single    endoscopic    cholangio    pig    restore    procedural    treatment    liver    bile    optimize    people    phantoms    safe    64    infections    gastrointestinal    boost    vascular    company   

Project "ENDOGI" data sheet

The following table provides information about the project.

Coordinator
ENDO GI MEDICAL LTD 

Organization address
address: 13 WADI EL HAJ
city: NAZARETH
postcode: 16000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.endo-gi.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ENDO GI MEDICAL LTD IL (NAZARETH) coordinator 50˙000.00

Map

 Project objective

Gastrointestinal diseases affect more than 70 M of people only in US and many of them, e.g. biliary/pancreatic disorders, can have as a consequence biliary, pancreatic or other duct's narrowing (stenosis). In these cases, there is an urgent need to restore lumen patency and drainage in order to prevent complications (e.g. jaundice, infections, liver disease), and they are often treated long-term by stent placement with an ERCP (Endoscopic Retrograde Cholangio-Pancreatography). However, ERCP stenting (specially for multiple stents) still represents many potential complications, associated with extended procedural times and multiple cannulations, which increases the side-effects of the procedure and the ERCP and post-ERCP costs. EndoGI medical has developed the first patented multi-stent delivery system for treatment of biliary, pancreatic and urologic stenosis that allows the safe insertion of multiple plastic stents (MPS) in a controlled, secure and single step. It enables the insertion of 2 or more plastic stents in the bile, hepatic or urinary ducts at 1 endoscope passage and with securing the guidewire throughout the procedure. EndoGI system can reduce up to 50% the cost of hospitalization/day, up to 80% the cost of hospitalization derived from post-ERCP pancreatitis and up to 20% the costs of hospitalizations by ischemia, which represents a 64% of reduction in comparison with common procedure using MPS and 2 delivery systems. We have built-up a first prototype and preliminary tested it with human phantoms and pig models, and now we aim to optimize the device, completely validate it in clinical settings, obtain regulatory certifications and launch it to market. We will initially penetrate the non-vascular stents market and focus in biliary stenting to offer savings of Ëž€330 M/year only in EU. During Phase 1, we will carry out a detailed feasibility study to evaluate the opportunities our innovation has to disrupt the field and boost EndoGI company growth.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENDOGI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENDOGI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DetectInMen (2019)

Infection detection in human semen

Read More  

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More